文献速递食管胃疾病与幽门螺杆菌

培养药敏试验与下一代测序在幽门螺杆菌耐药检测中的比较

Comparison of Culture With Antibiogram to Next-Generation Sequencing Using Bacterial Isolates and Formalin-Fixed, Paraffin-Embedded Gastric Biopsies.
PubMed 文献 · Gastroenterology · 2021-07-19

该研究比较了靶向下一代测序(NGS)与基于培养的幽门螺杆菌药敏试验在临床分离株及配对FFPE胃活检组织中的一致性。结果显示,NGS对克拉霉素、左氧氟沙星、利福布汀和四环素的耐药检测与琼脂稀释法一致性良好,而对甲硝唑和阿莫西林一致性仅为一般。基于组织的NGS预测耐药具有较好准确性。

要点

  • NGS与培养法对克拉霉素耐药检测一致性极好(κ=0.90012)。
  • 对左氧氟沙星一致性良好(κ=0.78161),对甲硝唑和阿莫西林仅为一般。
  • FFPE组织NGS预测克拉霉素耐药准确性94.1%,阿莫西林95.9%。

核心结论

  • 与琼脂稀释法相比,NGS能可靠地从临床分离株和FFPE胃组织确定对克拉霉素、左氧氟沙星、利福布汀和四环素的耐药性。
  • 对甲硝唑和阿莫西林的耐药检测一致性仅为一般。
  • 基于培养的药敏试验可预测克拉霉素和左氧氟沙星的治疗结局。

研究设计与样本

  • 研究比较了靶向NGS与基于培养的药敏试验,使用临床幽门螺杆菌分离株和配对的FFPE胃活检组织。
  • 对阿莫西林、克拉霉素、甲硝唑和利福布汀,配对比较包括170株分离株和FFPE组织。
  • 对左氧氟沙星和四环素,配对比较包括57株分离株和FFPE组织。

主要发现

  • 培养分离株的琼脂稀释法与NGS一致性:克拉霉素κ=0.90012,左氧氟沙星κ=0.78161,甲硝唑κ=0.55880,阿莫西林κ=0.21400。
  • 仅1株分离株对四环素耐药(培养法),1株对利福布汀耐药(NGS)。
  • 同一胃的组织块NGS与分离株琼脂稀释法比较,预测耐药的准确性:克拉霉素94.1%,阿莫西林95.9%,甲硝唑77%,左氧氟沙星87.7%,四环素98.2%。
  • 由于缺乏耐药,四环素和利福布汀的比较受限。

临床怎么用

  • NGS可用于从临床分离株或FFPE胃组织检测幽门螺杆菌对克拉霉素、左氧氟沙星、利福布汀和四环素的耐药性。
  • 对甲硝唑和阿莫西林的耐药检测,NGS与培养法一致性一般,解读需谨慎。

局限性

  • 四环素和利福布汀因耐药菌株极少而无法充分比较。
  • 需进一步研究比较两种方法预测其他抗生素治疗结局的能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The decline in Helicobacter pylori cure rates emphasizes the need for readily available methods to determine antimicrobial susceptibility. Our aim was to compare targeted next-generation sequencing (NGS) and culture-based H pylori susceptibility testing using clinical isolates and paired formalin-fixed, paraffin-embedded (FFPE) gastric biopsies. METHODS: H pylori isolates and FFPE tissues were tested for susceptibility to amoxicillin, clarithromycin, metronidazole, levofloxacin, tetracycline, and rifabutin using agar dilution and NGS targeted to 23S rRNA, gyrA, 16S rRNA, pbp1, rpoB and rdxA. Agreement was quantified using κ statistics. RESULTS: Paired comparisons included 170 isolates and FFPE tissue for amoxicillin, clarithromycin, metronidazole, and rifabutin and 57 isolates and FFPE tissue for levofloxacin and tetracycline. Agreement between agar dilution and NGS from culture isolates was very good for clarithromycin (κ = 0.90012), good for levofloxacin (κ = 0.78161) and fair for metronidazole (κ = 0.55880), and amoxicillin (κ = 0.21400). Only 1 isolate was resistant to tetracycline (culture) and 1 to rifabutin (NGS). Comparison of NGS from tissue blocks and agar dilution from isolates from the same stomachs demonstrated good accuracy to predict resistance for clarithromycin (94.1%), amoxicillin (95.9%), metronidazole (77%), levofloxacin (87.7%), and tetracycline (98.2%). Lack of resistance precluded comparisons for tetracycline and rifabutin. CONCLUSIONS: Compared with agar dilution, NGS reliably determined resistance to clarithromycin, levofloxacin, rifabutin, and tetracycline from clinical isolates and formalin-fixed gastric tissue. Consistency was fair for metronidazole and amoxicillin. Culture-based testing can predict treatment outcomes with clarithromycin and levofloxacin. Studies are needed to compare the relative ability of both methods to predict treatment outcomes for other antibiotics.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Hulten KG, Genta RM, Kalfus IN, et al. Comparison of Culture With Antibiogram to Next-Generation Sequencing Using Bacterial Isolates and Formalin-Fixed, Paraffin-Embedded Gastric Biopsies. Gastroenterology. 2021. PMID: 34293298. doi:10.1053/j.gastro.2021.07.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。